Loading...
Chemical structure of Fiboflapon Sodium

GC15506

Fiboflapon Sodium

Also listed as GSK2190915 sodium salt

GSK2190915 sodium salt (GSK2190915; AM-803) is a potent and orally bioavailable 5-lipoxygenase-activating protein (FLAP) inhibitor with a potency of 2·9 nM in FLAP binding, an IC50 of 76 nM for inhibition of LTB4 in human blood

ChemicalCAS1196070-26-4MW659.81FormulaC38H42N3NaO4S
CAS number
1196070-26-4
Molecular weight
659.81
Formula
C38H42N3NaO4S
Solubility
DMSO ： 100 mg/mL (151·56 mM; Need ultrasonic)
InChIKey
NOJNFULGOQGBKB-UHFFFAOYSA-M
Catalogue number
GC15506
Brand
GLPBIO
Computed properties PubChem CID 44473150 · TPSA 115 Ų · H-bond donors 0 · H-bond acceptors 7
TPSA
115 Ų
H-bond donors
0
H-bond acceptors
7
Rotatable bonds
13
Heavy atoms
47

SMILES CCOC1=NC=C(C=C1)C2=CC=C(C=C2)CN3C4=C(C=C(C=C4)OCC5=NC=C(C=C5)C)C(=C3CC(C)(C)C(=O)[O-])SC(C)(C)C.[Na+]

Computed descriptors from PubChem (CID 44473150), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.